Skip to main content
. Author manuscript; available in PMC: 2015 Dec 1.
Published in final edited form as: Curr Trop Med Rep. 2014 Sep 27;1(4):181–193. doi: 10.1007/s40475-014-0029-4

Table 2a.

Summary of results and potential for bias of articles published on the effectiveness of community-based control strategies aimed at reducing human cysticercosis, taeniasis or neurocysticercosis or at improving knowledge, attitudes and practices (KAP).

Country
[reference]
Results Potential for bias
Information
bias
Confounding Selection bias Clustering/
non
independence
Power/
generalizability
Other
Mexico [10] Taeniasis
Pre: 1.4% (4 cases / 302); Post: 0%
*PPR: 0 (95%§CI: undefined)
Antibodies to Cysticercosis:
Pre: 10.7%; Post: 7.4%
PPR: 0.65 (95%CI: 0.39; 1.10)
High: poor
tests
High: not
controlled; no
randomization
Moderate:
some losses to
follow-up
Ignored/
ignored
Poor / poor
25%
participation in
village
Clustering of cases
noted
Mexico [11] Taeniasis
Pre: 2.0% (matched); 1.1% (unmatched)
6 mo.: 1.0% (matched); 0.5% (unmatched)
42 mo.: 0.7% (matched); 0.5% (unmatched)
PPR (6 mo unmatched): 0.47 (95%CI: 0.20-1.11)
PPR (42 mo unmatched): 0.44 (95%CI: 0.13-1.47)
Seroprevalence (EITB):
Pre: 7.1% (matched); 5.7% (unmatched)
6 mo.: 10.7% (matched) 10.1% (unmatched)
42 mo: 1.8% (matched); 2.2% (unmatched)
PPR (6 mo unmatched): 1.77 (95%CI: 1.38-2.29)
PPR (42 mo unmatched): 0.39 (95%CI: 0.17-0.88)
Low: valid
tests
High: not
controlled; no
randomization
High: many
losses to follow-
up at 42
months
Ignored/
Ignored even in
“individual”
analysis
Poor / poor Increase in
prevalence of
cysticercosis at 6
months (those
positive lost to
follow-up?);
inappropriate
statistical analyses
Guatemala
[12]
Taeniasis
Pre: 3.5%; Post: 1%
PPR: 0.28 (95%CI: 0.15-0.53)
Low: valid test High: not
controlled; no
randomization
Modertae:
some losses to
follow-up
Ignored/
ignored
Poor / poor Taeniasis incidence
rate post treatment:
0.96 / 100 person-
years. Side effect of
niclosamide not
monitored
Mexico [13] Taeniasis
Pre: 0.8%; Post: 0.5%.
PPR: 0.64 (95%CI: 0.21-2.02)
¥KAP: improvement of knowledge on life cycle;
not defecation or washing hand/food
Low: valid
tests, low
High: not
controlled; no
randomization
High: many
losses to follow-
up, sampling
not described
Ignored/
ignored
Poor / poor Generally well
described study
Kenya [14] KAP
General improvement in knowledge on the life
cycle and in practices for pig management
(tethering)
Moderate:
self-reported
questionnaire
High: not
controlled, no
randomization
Moderate:
some losses-to-
follow-up
Ignored / well
described but
unclear if
appropriately
applied
Good at the
individual level,
poor otherwise/
unknown
Data in Table does
not agree with
described paired
analyses. Losses to-
follow-up may
bethose with least
knowledge
Tanzania [9] KAP
Improvement pre-post in knowledge about
porcine cysticercosis and prevention in both
groups. Practice of not eating undercooked pork
improved in intervention compared to control
group.
Moderate:
self-reported
questionnaire;
Low: randomized
and paired
Moderate:
losses to-
follow-up (not
at the village
level)
Group analysis/
paired analysis
Good / good for
Mbulu
Study well described.
Monitoring alone
improves knowledge
and practices.
Ecuador [20] Taeniasis
Pre: 2.2%; Post: 0%
PPR: 0 (95%CI: undefined)
Very high:
Very poor test
High: not
controlled; no
randomization
High: sampling
not described
Ignored/
ignored
Poor / poor Poor description of
study. Unrealistic
cost estimate.
Honduras [15] % NCC among People With Active Epilepsy:
Onset pre 1997: 36.7% (27/74)
Onset post 1997: 13.9% (5/36)
PPR: 0.38 (95%CI: 0.16-0.89)
Low: valid
tests
High: not
controlled; no
randomization
Moderate:mmi
gration of new
onset seizures
may have
occurred
Ignored / only
new cases of
epilepsy included
in the follow-up
Poor / Salama
county
Unclear if door-to-
door survey done
every year.
*

PPR: Prevalence Proportion Ratio

§

CI : Confidence Interval

¥

KAP: Knowledge, attitudes and practices